Target intelligence / Profile preview

Leucine-rich repeat protein SHOC-2 (SHOC2)

Target
SHOC2
Molecular classification
Scaffold protein
01

Overview

Leucine-rich repeat protein SHOC-2 is a highly conserved scaffold protein consisting primarily of leucine-rich repeats (LRRs) that form a horseshoe-shaped structure for protein-protein interactions. It serves as a core component of the SHOC2-MRAS-PP1c (SMP) complex, which dephosphorylates inhibitory sites on RAF kinases (Ser-259 on RAF1, Ser-365 on BRAF, Ser-214 on ARAF), thereby activating the RAF-MEK-ERK MAPK signaling cascade downstream of RAS. This scaffolding enhances signal specificity, amplitude, and spatial control, including endosomal targeting, while interacting with regulators like HUWE1 (for ubiquitination) and PSMC5 (for complex remodeling). SHOC-2 is essential for embryogenesis, as its knockout causes lethality in mice due to heart defects, and it promotes cell proliferation and self-renewal in neuronal progenitors. Gain-of-function mutations, such as S2G, cause Noonan-like syndrome with loose anagen hair by hyperactivating ERK signaling via aberrant membrane targeting. In cancer, SHOC-2 sustains ERK activity in tumors with RAS or RAF mutations, contributing to resistance against BRAF inhibitors like vemurafenib and promoting motility and anchorage-independent growth. No approved drugs directly target SHOC-2, but its central role in RASopathy signaling positions it as a potential therapeutic target, though challenges include avoiding developmental toxicity.

Other names
Leucine rich repeat scaffold proteinSur-8SHOC-2
02

Biological functions

Signal transduction (RAS/ERK MAPK pathway)Protein dephosphorylation regulation (via SMP complex)EmbryogenesisCell proliferation
03

Disease associations

Noonan-like syndrome with loose anagen hairCancer (e.g., melanoma resistance, proliferation)
04

Safety considerations

Embryonic lethality upon loss of functionDevelopmental deficiencies from mutations

Beyond the preview

Go deeper on Leucine-rich repeat protein SHOC-2 (SHOC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat protein SHOC-2 (SHOC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call